​

CVS Health (CVS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CVS Stock Forecast

CVS Health (CVS) stock forecast, based on 41 Wall Street analysts, predicts a 12-month average price target of $103.64, with a high of $115.00 and a low of $90.00. This represents a 3.14% increase from the last price of $100.48.

$40 $55 $70 $85 $100 $115 High: $115 Avg: $103.64 Low: $90 Last Closed Price: $100.48

CVS Stock Rating

CVS Health stock's rating consensus is Buy, based on 41 Wall Street analysts. The breakdown includes 2 Strong Buy (4.88%), 33 Buy (80.49%), 6 Hold (14.63%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 41 0 6 33 2 Strong Sell Sell Hold Buy Strong Buy

CVS Price Target Upside V Benchmarks

TypeNameUpside
StockCVS Health3.14%
SectorHealthcare Stocks 15.45%
IndustryHealthcare Plans Stocks1.81%

Price Target Trends

1M3M12M
# Anlaysts81335
Avg Price Target$109.38$105.46$96.97
Last Closing Price$100.48$100.48$100.48
Upside/Downside8.86%4.96%-3.49%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 266184--28
May, 266183--27
Apr, 266184--28
Mar, 266175--28
Feb, 266174--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 08, 2026Mizuho Securities$115.00$95.9319.88%14.45%
Jun 04, 2026Morgan Stanley$111.00$91.3721.48%10.47%
Jun 01, 2026Truist Financial$108.00$90.9818.71%7.48%
Jun 01, 2026Jessica TassanPiper Sandler$113.00$90.9824.20%12.46%
May 26, 2026Andrew MokBarclays$106.00$91.6315.68%5.49%
May 20, 2026Mizuho Securities$110.00$94.1816.80%9.47%
May 14, 2026Morgan Stanley$106.00$97.858.33%5.49%
May 13, 2026Bernstein$106.00$95.1511.40%5.49%
May 07, 2026RBC Capital$107.00$86.5623.61%6.49%
May 07, 2026Deutsche Bank$92.00$87.465.19%-8.44%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 11, 2026Cantor FitzgeraldOverweightOverweighthold
Jun 04, 2026Morgan StanleyOverweightOverweighthold
Jun 01, 2026Piper SandlerOverweightOverweighthold
May 14, 2026Morgan StanleyOverweightOverweighthold
May 13, 2026BernsteinOutperformOutperformhold
May 11, 2026Cowen & Co.BuyBuyhold
May 08, 2026Wells FargoOverweightOverweighthold
May 07, 2026RBC CapitalOutperformOutperformhold
May 07, 2026Deutsche BankBuyBuyhold
May 07, 2026BarclaysOverweightOverweighthold

Financial Forecast

EPS Forecast

$1 $3 $5 $7 $9 $11 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.00$3.29$6.49$3.66$1.40---
Avg Forecast$8.25$8.63$8.61$5.15$5.87$6.88$8.19$10.15
High Forecast$8.43$8.95$8.64$5.81$7.03$8.43$8.98$10.69
Low Forecast$8.09$8.32$8.59$4.65$5.34$5.83$7.49$9.66
Surprise %-27.27%-61.88%-24.62%-28.93%-76.15%---

Revenue Forecast

$250B $300B $350B $400B $450B $500B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$292.11B$322.47B$357.78B$372.81B$402.07B---
Avg Forecast$290.59B$315.12B$354.36B$371.88B$385.40B$405.34B$421.93B$443.77B
High Forecast$295.45B$324.21B$356.91B$373.69B$401.00B$405.76B$424.16B$461.94B
Low Forecast$286.05B$306.42B$351.62B$367.69B$372.45B$404.92B$419.69B$427.19B
Surprise %0.52%2.33%0.96%0.25%4.32%---

Net Income Forecast

$0 $3B $6B $9B $12B $15B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.00B$4.31B$8.34B$4.61B$1.77B---
Avg Forecast$6.83B$7.85B$8.34B$6.75B$7.97B$9.20B$10.62B$13.09B
High Forecast$8.19B$9.42B$10.01B$7.50B$9.06B$10.88B$11.58B$13.79B
Low Forecast$5.46B$6.28B$6.68B$6.00B$6.88B$7.52B$9.66B$12.46B
Surprise %17.17%-45.10%--31.65%-77.83%---

CVS Forecast FAQ

Is CVS Health stock a buy?

CVS Health stock has a consensus rating of Buy, based on 41 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 33 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CVS Health is a favorable investment for most analysts.

What is CVS Health's price target?

CVS Health's price target, set by 41 Wall Street analysts, averages $103.64 over the next 12 months. The price target range spans from $90 at the low end to $115 at the high end, suggesting a potential 3.14% change from the previous closing price of $100.48.

How does CVS Health stock forecast compare to its benchmarks?

CVS Health's stock forecast shows a 3.14% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the healthcare plans stocks industry (1.81%).

What is the breakdown of analyst ratings for CVS Health over the past three months?

  • June 2026: 21.43% Strong Buy, 64.29% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 22.22% Strong Buy, 66.67% Buy, 11.11% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 21.43% Strong Buy, 64.29% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is CVS Health’s EPS forecast?

CVS Health's average annual EPS forecast for its fiscal year ending in December 2026 is $6.88, marking a 391.43% increase from the reported $1.4 in 2025. Estimates for the following years are $8.19 in 2027, and $10.15 in 2028.

What is CVS Health’s revenue forecast?

CVS Health's average annual revenue forecast for its fiscal year ending in December 2026 is $405.34B, reflecting a 0.81% increase from the reported $402.07B in 2025. The forecast for 2027 is $421.93B, and $443.77B for 2028.

What is CVS Health’s net income forecast?

CVS Health's net income forecast for the fiscal year ending in December 2026 stands at $9.2B, representing an 420.34% increase from the reported $1.77B in 2025. Projections indicate $10.62B in 2027, and $13.09B in 2028.